MoneyWorks4Me

The company witnessed a 14.86% growth in the revenue at Rs. 9244.20 millions for the quarter ended June 2026 as compared to Rs. 8048.30 millions during the year-ago period.Profit saw a slight increase of 23.76%to Rs. 2533.30  millions from Rs. 2047.00 millions.Operating profit surged to 3547.90 millions from the corresponding previous quarter of 2945.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 9244.20 8048.30 14.86 9244.20 8048.30 14.86 37902.00 37234.90 1.79
Other Income 616.30 437.60 40.84 616.30 437.60 40.84 1425.60 1425.60 0.00
PBIDT 3547.90 2945.10 20.47 3547.90 2945.10 20.47 14427.60 13118.50 9.98
Interest 9.70 4.20 130.95 9.70 4.20 130.95 27.30 13.10 108.40
PBDT 3538.20 2940.90 20.31 3538.20 2940.90 20.31 14426.70 13152.30 9.69
Depreciation 158.40 155.20 2.06 158.40 155.20 2.06 664.40 667.90 -0.52
PBT 3379.80 2785.70 21.33 3379.80 2785.70 21.33 13762.30 12484.40 10.24
TAX 846.50 738.70 14.59 846.50 738.70 14.59 3644.10 3293.80 10.64
Deferred Tax 33.00 0.20 16400.00 33.00 0.20 16400.00 94.60 62.00 52.58
PAT 2533.30 2047.00 23.76 2533.30 2047.00 23.76 10118.20 9190.60 10.09
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 38.38 36.59 4.88 38.38 36.59 4.88 38.07 35.23 8.04
Peers
Company Name CMP
Sun Pharma. Inds. 1847.55
Dr. Reddys Labs. 1142.10
Cipla 1355.20
Lupin 2043.20
Zydus Lifesciences 1097.20
View more..